Adial Pharmaceuticals

About Adial Pharmaceuticals

Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on the treatment and prevention of addictions and other unmet medical needs, with a particular emphasis on developing therapies for addiction and related disorders.

Products & Services

AD04:A genetically targeted, serotonin-3 receptor antagonist therapeutic agent for the treatment of Alcohol Use Disorder (AUD), currently under investigation for patients with specific genotypes identified using a proprietary companion diagnostic genetic test.

Specialties

Addiction treatment Alcohol Use Disorder (AUD) therapies Precision medicine Genetic targeting

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Warrant Inducement T: - FT: Warrant Inducement	A: 2860000 MR: - FA: approximately $2.86 million FAN: 2860000	D: 2025-11-26 FD: 2025-11-26	1 investors
2	RT: Public Offering T: - FT: Public Offering	A: 3600000 MR: - FA: $3.6 million FAN: 3600000	D: 2025-06-17 FD: 2025-06-17	1 investors
3	RT: Warrant Inducement T: - FT: Warrant Inducement	A: 2750000 MR: - FA: approximately $2.75 million FAN: 2750000	D: 2025-05-02 FD: 2025-05-02	1 investors
4	RT: Warrant Exercise T: - FT: Warrant Exercise	A: 3530500 MR: - FA: $3,530,500 FAN: 3530500	D: 2024-03-01 FD: 2024-03-01	-
5	RT: Private Placement T: - FT: Private Placement	A: 4000000 MR: - FA: approximately $4 million FAN: 4000000	D: 2023-10-24 FD: 2023-10-24	-
6	RT: Private Placement T: - FT: Private Placement	A: 4000000 MR: - FA: approximately $4 million FAN: 4000000	D: 2023-10-20 FD: 2023-10-20	-
7	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 750000 MR: - FA: 0.75 million FAN: 750000	D: 2023-02-24 FD: 2023-02-24	1 investors

Warrant Inducement Latest

2025-11-26

$2.9M

1 investor (Pro only)

Public Offering 2025-06-17

$3.6M

Warrant Inducement 2025-05-02

$2.8M

View 6 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

Kevin Schuyler

Chairman of the Board

LinkedIn (Pro only)

J

J. Kermit Anderson

Member - Board of Directors

LinkedIn (Pro only)

R

Robin Gilliland

Member - Board of Directors

J

James W. Newman, Jr.

Member - Board of Directors

C

Cary J. Claiborne

Chief Executive Officer

T

Tony Goodman

Chief Operating Officer

View 9 more team members with Pro

Unlock Full Team Directory

Recent News